413 related articles for article (PubMed ID: 20139361)
1. Periprocedural anticoagulation management of patients with venous thromboembolism.
McBane RD; Wysokinski WE; Daniels PR; Litin SC; Slusser J; Hodge DO; Dowling NF; Heit JA
Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):442-8. PubMed ID: 20139361
[TBL] [Abstract][Full Text] [Related]
2. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
Douketis JD; Johnson JA; Turpie AG
Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
[TBL] [Abstract][Full Text] [Related]
3. Risk of thromboembolism with short-term interruption of warfarin therapy.
Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM
Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197
[TBL] [Abstract][Full Text] [Related]
4. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
Kovacs MJ; Kearon C; Rodger M; Anderson DR; Turpie AG; Bates SM; Desjardins L; Douketis J; Kahn SR; Solymoss S; Wells PS
Circulation; 2004 Sep; 110(12):1658-63. PubMed ID: 15364803
[TBL] [Abstract][Full Text] [Related]
5. Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients.
Daniels PR; McBane RD; Litin SC; Ward SA; Hodge DO; Dowling NF; Heit JA
Thromb Res; 2009 Jul; 124(3):300-5. PubMed ID: 19232682
[TBL] [Abstract][Full Text] [Related]
6. Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation.
Wysokinski WE; McBane RD; Daniels PR; Litin SC; Hodge DO; Dowling NF; Heit JA
Mayo Clin Proc; 2008 Jun; 83(6):639-45. PubMed ID: 18533080
[TBL] [Abstract][Full Text] [Related]
7. Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study.
Pengo V; Cucchini U; Denas G; Erba N; Guazzaloca G; La Rosa L; De Micheli V; Testa S; Frontoni R; Prisco D; Nante G; Iliceto S;
Circulation; 2009 Jun; 119(22):2920-7. PubMed ID: 19470892
[TBL] [Abstract][Full Text] [Related]
8. Variations in perioperative warfarin management: outcomes and practice patterns at nine hospitals.
Jaffer AK; Brotman DJ; Bash LD; Mahmood SK; Lott B; White RH
Am J Med; 2010 Feb; 123(2):141-50. PubMed ID: 20103023
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
10. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
11. A review of the practical advantages of low molecular weight heparin in the treatment of cancer-related venous thromboembolism.
Rhodes S; Bond S
Eur J Oncol Nurs; 2008 Dec; 12(5):425-9. PubMed ID: 18842458
[TBL] [Abstract][Full Text] [Related]
12. A practical approach for bridging anticoagulation after mechanical heart valve replacement.
Steger V; Bail DH; Graf D; Walker T; Rittig K; Ziemer G
J Heart Valve Dis; 2008 May; 17(3):335-42. PubMed ID: 18592932
[TBL] [Abstract][Full Text] [Related]
13. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
14. Periprocedural bridging management of anticoagulation.
Wysokinski WE; McBane RD
Circulation; 2012 Jul; 126(4):486-90. PubMed ID: 22825410
[No Abstract] [Full Text] [Related]
15. Perioperative management of long-term anticoagulation.
Kearon C
Semin Thromb Hemost; 1998; 24 Suppl 1():77-83. PubMed ID: 9840696
[TBL] [Abstract][Full Text] [Related]
16. Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures.
Clark NP; Witt DM; Davies LE; Saito EM; McCool KH; Douketis JD; Metz KR; Delate T
JAMA Intern Med; 2015 Jul; 175(7):1163-8. PubMed ID: 26010033
[TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practice.
Soto-Cárdenas MJ; Pelayo-García G; Rodríguez-Camacho A; Segura-Fernández E; Mogollo-Galván A; Giron-Gonzalez JA
Palliat Med; 2008 Dec; 22(8):965-8. PubMed ID: 18952751
[TBL] [Abstract][Full Text] [Related]
18. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV
Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic anticoagulation in the trauma patient: is it safe?
Golob JF; Sando MJ; Kan JC; Yowler CJ; Malangoni MA; Claridge JA
Surgery; 2008 Oct; 144(4):591-6; discussion 596-7. PubMed ID: 18847643
[TBL] [Abstract][Full Text] [Related]
20. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]